Keyphrases
Antiviral Activity
100%
In Silico
100%
Repurposing
100%
In Vitro Assessment
100%
Fidaxomicin
100%
SARS-CoV-2 Mpro
100%
COVID-19
50%
In Silico Screening
25%
Drug Development
25%
Antiretroviral Therapy
25%
Novel Antivirals
25%
Protease Inhibitors
25%
Safety Profile
25%
Therapeutic Candidates
25%
COVID-19 Pandemic
25%
Antiviral Properties
25%
Drug-resistant Virus
25%
Rapid Development
25%
Papain-like
25%
DrugBank Database
25%
Medicine and Dentistry
In Vitro
100%
Antiviral Activity
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
In Silico
100%
Fidaxomicin
100%
Proteinase Inhibitor
25%
COVID-19
25%
Antiviral Therapy
25%
Papain
25%
Virus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Activity
100%
SARS Coronavirus
100%
Fidaxomicin
100%
Antivirus Agent
25%
Drug Development
25%
Antiviral Therapy
25%
Proteinase Inhibitor
25%
Papain
25%
Pandemic
25%
Repurposing
25%